RxDoctor Payments Data

Milton Schleve, MD

MOHS-Micrographic Surgery · Denver, CONPI 1316994965

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 26.7% of the total.

$3,196in general payments, 2019–2025

Across 149 payments — averaging $21.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$855
  • Sanofi$448
  • Novartis$414
  • Regeneron Healthcare Solutions, Inc.$237
  • Johnson & Johnson$212
  • E.r. Squibb & Sons, L.L.C.$187
  • plus $844 from 16 others

What the payments were for

  • Food & beverage$3,196100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,196 in reported general payments places this provider in the 55th percentile of 37 mohs-micrographic surgery providers in Colorado.

See all mohs-micrographic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$143,838
Medicare patients
552
Services billed
2,548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole11$1,653
Clobetasol Propionate40$1,316
Ketoconazole55$1,085
Clindamycin Phosphate23$999
Doxycycline Hyclate31$629
ValacyclovirValacyclovir Hcl14$586
Triamcinolone Acetonide63$561
Fluorouracil12$522
Mupirocin24$228
Minoxidil13$208
Hydrocortisone22$100
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$74
Cephalexin12$73

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →